(Q38329996)

2 September 2017

Loss of expression of the adipocyte-type fatty acid-binding protein (A-FABP) is associated with progression of human urothelial carcinomas (English)

1 reference

2 September 2017

0 references

1 reference

Gita Ohlsson

1

1 reference

2 September 2017

José M A Moreira

2

1 reference

2 September 2017

Pavel Gromov

3

1 reference

2 September 2017

Guido Sauter

4

1 reference

2 September 2017

Julio E Celis

5

1 reference

2 September 2017

25 February 2005

1 reference

Molecular & Cellular Proteomics

2 September 2017

1 reference

2 September 2017

4

1 reference

2 September 2017

570-581

1 reference

2 September 2017

4

1 reference

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Identifying distinct classes of bladder carcinoma using microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Expression array technology in the diagnosis and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Impact of proteomics on bladder cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Proteomic strategies in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Cytoplasmic fatty acid binding protein: significance for intracellular transport of fatty acids and putative role on signal transduction pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Fatty acids in cell signalling: modulation by lipid binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Functional analysis of peroxisome-proliferator-responsive element motifs in genes of fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Applications of array technology: identification of molecular targets in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Classification of bladder cancer by microarray expression profiling: towards a general clinical use of microarrays in cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Gene discovery in bladder cancer progression using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M500017-MCP200

10.1074/MCP.M500017-MCP200

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference